FINWIRES · TerminalLIVE
FINWIRES

加拿大帝国商业银行(CIBC)在Linamar第一季度业绩公布后,将目标股价从105加元上调至110加元。

By

-- 在Linamar(LNR.TO)周三公布第一季度业绩后,加拿大帝国商业银行资本市场(CIBC Capital Markets)维持了对该公司股票的“跑赢大盘”评级,并将目标价从105加元上调至110加元。 CIBC表示,Linamar第一季度业绩“远超预期”,除受232条款关税调整的影响外,其业绩“正朝着”LNR最初的预期稳步迈进。 CIBC指出:“关税的额外影响导致工业和综合利润率预期下调,但这两个业务板块强劲的销售前景推动我们小幅上调了年度营业收入(AOI)预测,并将目标价从105加元上调至110加元。我们认为这很可能只是暂时的盈利减值,而非永久性影响。总体而言,Linamar的业绩表明其基本面健康,且执行良好。其估值仍然具有吸引力(CIBC 2026年预期EBITDA的3.8倍),我们维持“跑赢大盘”评级。” 加拿大帝国商业银行 (CIBC) 表示,移动出行业务的强劲销售增长主要得益于近期收购、新业务拓展以及现有项目的销量增长。CIBC 指出:“管理层仍然看到许多潜在的困境企业并购机会,尤其是在欧洲。” CIBC 表示,工业板块的优异表现主要得益于 Skyjack 市场份额的持续增长,其销量同比增长 66%,这主要得益于创新以及人工智能相关建设项目的需求。CIBC 还指出:“受农民信心疲软的影响,农业业务持续下滑,但公司注意到被压抑的需求、经销商库存水平更加平衡以及下半年可能出现的纾困金利好因素。” “LNR 预计 2026/2027 年无障碍市场将温和增长,而北美农业市场预计在 2026 年将下降 15%-20%。” CIBC 表示,232 条款钢铝关税的变化从第二季度开始对工业业务的利润率产生“负面影响”,但对移动出行业务没有影响。加拿大帝国商业银行 (CIBC) 预计,该业务板块的利润率将面临约 300 个基点的下行压力,但这一数字尚不确定,且可能随时变动。 CIBC 补充道:“该指引反映了已采取的缓解措施,但 LNR 仍在探索各种替代方案。重点在于低成本、低投入的措施,LNR 目前不考虑转移生产。”

Price: $96.50, Change: $+5.84, Percent Change: +6.44%

Related Articles

Insider Trading

Teva Pharmaceutical Industries Insider Sold Shares Worth $384,444, According to a Recent SEC Filing

Amir Weiss, Chief Accounting Officer, on May 06, 2026, sold 10,679 shares in Teva Pharmaceutical Industries (TEVA) for $384,444. Following the Form 4 filing with the SEC, Weiss has control over a total of 20,016 ordinary shares of the company, with 20,016 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/818686/000119312526211855/xslF345X05/ownership.xml

$TEVA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Doordash, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $2 to $240, based on 30x our 2027 EPS view, just below DASH's three-year average (~32x) given competitive threats from AI and Uber Eats, offset by the company's dominant market position and positive network effects. We raise our 2026 adjusted EPS view by $0.10 to $5.63 and 2027's by $0.06 to $7.99. We are encouraged by DASH's Q2 Marketplace GOV guidance (+36% Y/Y), an encouraging result following relatively soft guidance for Q1, especially given fears of a weakening consumer. International sales continue to scale solidly, with Deliveroo accelerating to 14% Y/Y growth in Q1 vs. 7% growth in Q4 (we expect continued improvement all year). Margin pressure remains (adjusted EBITDA margin -20 bps Y/Y to 2.4%) but should fade as platform integration activities finish up early next year. Adjusted EBITDA guidance (midpoint of $820M) was above expectations ($742M), despite the company expecting another $50M gas relief charge, which should persist amid the Strait of Hormuz closure.

$DASH
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Tyson Foods, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target remains $76, a 15x multiple of projected FY 27 EPS of $5.09 (raised by $0.02). We also lift our FY 26 (Sep.) EPS est. by $0.09 to $4.11. This multiple is slightly above TSN's long-term average of 14x, reflecting favorable secular tailwinds, including a continued shift in consumer preferences toward protein and improved earnings growth potential as the Beef segment recovers, likely in FY 27. Operationally, TSN is executing well, particularly in Chicken, where margins continue to widen, up 290 bps year over year in FQ2. Beef remains pressured by historically tight cattle supplies, with the U.S. herd at its lowest level since 1951, though we expect margins to improve following recent restructuring actions, including rightsizing production to improve capacity utilization. TSN's balance sheet is solid, noting its leverage ratio (net debt/adjusted EBITDA) has now improved to 2.2x vs. 3.9x two years ago. This provides a decent degree of financial flexibility in our view.

$TSN